Transplantation of spinal cord–derived neural stem cells for ALS: analysis of phase 1 and 2 trials

JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici… - Neurology, 2016 - AAN Enterprises
Objective: To test the safety of spinal cord transplantation of human stem cells in patients
with amyotrophic lateral sclerosis (ALS) with escalating doses and expansion of the trial to …

Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials.

JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici… - Neurology, 2016 - europepmc.org
Objective To test the safety of spinal cord transplantation of human stem cells in patients with
amyotrophic lateral sclerosis (ALS) with escalating doses and expansion of the trial to …

[引用][C] Transplantation of spinal cord–derived neural stem cells for ALS

JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici… - Neurology, 2016 - cir.nii.ac.jp
Transplantation of spinal cord–derived neural stem cells for ALS | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials

JD Glass, VS Hertzberg, NM Boulis, J Riley… - …, 2016 - pubmed.ncbi.nlm.nih.gov
Objective To test the safety of spinal cord transplantation of human stem cells in patients with
amyotrophic lateral sclerosis (ALS) with escalating doses and expansion of the trial to …

Transplantation of spinal cord–derived neural stem cells for ALS

JD Glass, VS Hertzberg, NM Boulis, J Riley… - …, 2016 - ingentaconnect.com
Objective: To test the safety of spinal cord transplantation of human stem cells in patients
with amyotrophic lateral sclerosis (ALS) with escalating doses and expansion of the trial to …

[HTML][HTML] Transplantation of spinal cord–derived neural stem cells for ALS: Analysis of phase 1 and 2 trials

JD Glass, VS Hertzberg, NM Boulis, J Riley, T Federici… - Neurology, 2016 - ncbi.nlm.nih.gov
Objective: To test the safety of spinal cord transplantation of human stem cells in patients
with amyotrophic lateral sclerosis (ALS) with escalating doses and expansion of the trial to …